Telomere length in club cells integrates oxidative informational entropy generated during CYP450-mediated detoxification rather than merely counting divisions. We hypothesize that the efficiency of electron coupling within CYP450 enzymes directly governs the rate of telomeric damage, such that enhancing coupling reduces ROS leakage and slows telomere attrition independent of telomerase activity. Specifically, we propose that CYP450 isoforms (CYP2F1, CYP4B1, CYP2B6) form a transient metabolon with NADPH oxidase 4 (NOX4) and the shelterin complex, channeling electrons to produce localized superoxide preferentially at telomeric G-quadruplex structures. When CYP450 uncoupling increases, electrons escape to oxygen, amplifying ROS production at these hotspots and accelerating 8-oxoG lesions and single-strand breaks that drive telomere shortening. Conversely, compounds that improve heme‑iron stability or optimize NADPH binding (e.g., certain heme analogs or flavin mononucleotide derivatives) should tighten coupling, diminish telomeric ROS, and preserve telomere length even under high metabolic load.

This hypothesis is testable and falsifiable. In primary human airway club cells cultured at air‑liquid interface, we will treat cells with a prototypical CYP450 substrate (e.g., nicotine) alongside a coupling enhancer (e.g., heme‑pyrrole compound HPC-1) or a control vehicle. Measurements will include: (1) telomere length via qPCR and Telomere‑Specific FISH, (2) oxidative telomere damage via immunostaining for 8-oxoG at telomeres (using telomere‑peptide nucleic acid probes), (3) senescence-associated β‑galactosidase activity, and (4) CYP450 coupling efficiency assessed by NADPH consumption versus product formation ratios. We predict that coupling enhancers will significantly reduce telomeric 8-oxoG signals and slow telomere attrition relative to substrate‑only controls, without altering proliferation rates (measured by EdU incorporation).

In vivo, we will generate a lung‑specific, inducible club‑cell line overexpressing human CYP2F1. Mice will receive either the coupling enhancer or vehicle via intratracheal administration, followed by subchronic exposure to cigarette smoke extract (a known CYP450 inducer). After 4 weeks, we will quantify telomere length in isolated club cells (using flow‑FISH), assess fibrotic markers (α‑SMA, collagen I), and evaluate regenerative capacity after naphthalene‑induced injury (club cell repopulation index). The hypothesis predicts that enhancer‑treated mice will retain longer telomeres, show attenuated fibrosis, and exhibit superior epithelial repair compared to vehicle‑treated counterparts.

Falsification would occur if coupling enhancers fail to modify telomeric oxidative damage or telomere length despite verified increases in CYP450 coupling efficiency, indicating that telomere entropy is not tightly coupled to CYP450 electron leak. Conversely, confirmation would support a model where telomeres act as quantifiable readouts of enzymatic metabolic fidelity, positioning interventions that optimize oxidase coupling as a strategy to counteract aging‑related progenitor depletion in the lung.